A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. (Q40565608)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

title

A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Kathrin M. Bernt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

7

Nancy Kiviat

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Pavel Sova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Xiao-Wei Ren

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Shaoheng Ni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Jie Mi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

André Lieber

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 April 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

496-509

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15093180%20AND%20SRC:MED&resulttype=core&format=json

Toward a new generation of conditionally replicating adenoviruses: pairing tumor selectivity with maximal oncolysis

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Cellular immunity delimits adenoviral gene therapy strategies for the treatment of neoplastic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

A blood-tumor barrier limits gene transfer to experimental liver cancer: the effect of vasoactive compounds.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Determination of molecules regulating gene delivery using adenoviral vectors in ovarian carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

The therapeutic efficacy of adenoviral vectors for cancer gene therapy is limited by a low level of primary adenovirus receptors on tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Activation of innate immunity in nonhuman primates following intraportal administration of adenoviral vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Improved gene transfer efficiency to primary and established human pancreatic carcinoma target cells via epidermal growth factor receptor and integrin-targeted adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

A capsid-modified adenovirus vector devoid of all viral genes: assessment of transduction and toxicity in human hematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

CD46 is a cellular receptor for group B adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Levels of complement regulatory proteins, CD35 (CR1), CD46 (MCP) and CD55 (DAF) in human haematological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Expression of membrane cofactor protein (MCP, CD46) in human liver diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

The complement regulatory proteins CD46 and CD59, but not CD55, are highly expressed by glandular epithelium of human breast and colorectal tumour tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Human membrane cofactor protein (MCP, CD46): multiple isoforms and functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Tumor-specific gene expression in hepatic metastases by a replication-activated adenovirus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

A new type of adenovirus vector that utilizes homologous recombination to achieve tumor-specific replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Identification and characterization of a new member of the TNF family that induces apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Apo2L/TRAIL and its death and decoy receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Safety and antitumor activity of recombinant soluble Apo2 ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Suppression of tumor growth following intralesional therapy with TRAIL recombinant adenovirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Adenoviral-mediated transfer of the TNF-related apoptosis-inducing ligand/Apo-2 ligand gene induces tumor cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Antitumor activity and prolonged expression from a TRAIL-expressing adenoviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Expression and antitumor effects of TRAIL in human cholangiocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Combination of TRAIL gene therapy and chemotherapy enhances antitumor and antimetastasis effects in chemosensitive and chemoresistant breast cancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Characterization of in vitro and in vivo gene transfer properties of adenovirus serotype 35 vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

In vivo hepatic adenoviral gene delivery occurs independently of the coxsackievirus-adenovirus receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Membrane cofactor protein (MCP; CD46) expression in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

DNA replication of first-generation adenovirus vectors in tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

TRAIL (APO-2L) induces apoptosis in human prostate cancer cells that is inhibitable by Bcl-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Active caspases and cleaved cytokeratins are sequestered into cytoplasmic inclusions in TRAIL-induced apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Combined TRAIL and Bax gene therapy prolonged survival in mice with ovarian cancer xenograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Multiple species of CPP32 and Mch2 are the major active caspases present in apoptotic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Insulation from viral transcriptional regulatory elements enables improvement to hepatoma-specific gene expression from adenovirus vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Rearrangements in adenoviral genomes mediated by inverted repeats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Restoration of a functional open reading frame by homologous recombination between two adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Induced apoptosis supports spread of adenovirus vectors in tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Dependence of adenovirus infectivity on length of the fiber shaft domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Method for multiple portal vein infusions in mice: quantitation of adenovirus-mediated hepatic gene transfer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

High expression of membrane cofactor protein of complement (CD46) in human leukaemia cell lines: implication of an alternatively spliced form containing the STA domain in CD46 up-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistanc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Inhibition of TRAIL-induced apoptosis and forced internalization of TRAIL receptor 1 by adenovirus proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

E1B 19K inhibits Fas-mediated apoptosis through FADD-dependent sequestration of FLICE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

A multitasking oncolytic adenovirus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Increased expression of death receptors 4 and 5 synergizes the apoptosis response to combined treatment with etoposide and TRAIL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Improved production of adenovirus vectors expressing apoptotic transgenes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

An adenovirus E1A mutant that demonstrates potent and selective systemic anti-tumoral efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

Pre-existent adenovirus antibody inhibits systemic toxicity and antitumor activity of CN706 in the nude mouse LNCaP xenograft model: implications and proposals for human therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Generation of recombinant adenovirus vectors with modified fibers for altering viral tropism.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008

inferred from DOI database lookup

7 January 2021

based on heuristic

Generation of adenovirus vectors devoid of all viral genes by recombination between inverted repeats

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2003.12.008